Human clinical trials could begin as early as next year
A team of researchers at the University of Georgia’s Regenerative Bioscience Center and ArunA Biomedical, a UGA startup company, have developed a new treatment for stroke that reduces brain damage and accelerates the brain’s natural healing tendencies in animal models. They published their findings in the journal Translational Stroke Research.
The research team led by UGA professor Steven Stice and Nasrul Hoda of Augusta University created a treatment called AB126 using extracellular vesicles (EV), fluid-filled structures known as exosomes, which are generated from human neural stem cells.
Fully able to cloak itself within the bloodstream, this type of regenerative EV therapy appears to be the most promising in overcoming the limitations of many cell therapies—with the ability for exosomes to carry and deliver multiple doses—as well as the ability to store and administer treatment. Small in size, the tiny tubular shape of an exosome allows EV therapy to cross barriers that cells cannot.
“This is truly exciting evidence, because exosomes provide a stealth-like characteristic, invisible even to the body’s own defenses,” said Stice, Georgia Research Alliance Eminent Scholar and D.W. Brooks Distinguished Professor in the College of Agricultural and Environmental Sciences. “When packaged with therapeutics, these treatments can actually change cell progression and improve functional recovery.”
Following the administration of AB126, the researchers used MRI scans to measure brain atrophy rates in preclinical, age-matched stroke models, which showed an approximately 35 percent decrease in the size of injury and 50 percent reduction in brain tissue loss—something not observed acutely in previous studies of exosome treatment for stroke.
Outside of rodents, the results were replicated by Franklin West, associate professor of animal and dairy science, and fellow RBC members using a porcine model of stroke—the only one of its kind in the U.S.
Based on these pre-clinical results, ArunA Biomedical plans to begin human studies in 2019, said Stice, who is also chief scientific officer of ArunA Biomedical.
“Until now, we had very little evidence specific to neural exosome treatment and the ability to improve motor function,” said Stice. “Just days after stroke, we saw better mobility, improved balance and measurable behavioral benefits in treated animal models.”
Named as part of the ‘stroke belt’ region, Georgia continues to exceed the national average in stroke deaths, which is the third leading cause of death in the U.S., with more than 140,000 Americans dying each year, according to the Centers for Disease Control and Prevention.
ArunA recently unveiled advances to the company’s proprietary neural cell platform for the production of exosome manufacturing. Today, ArunA’s manufacturing process positions the company to produce AB126 exosomes at a scale to meet early clinical demand. The company has plans to expand this initiative beyond stroke for preclinical studies in epilepsy, traumatic brain and spinal cord injuries later this year.
The Latest on: Stroke treatment
via Google News
The Latest on: Stroke treatment
- Colchicine cuts odds of new heart attack, stroke in heart attack survivorson November 18, 2019 at 11:50 am
(Reuters Health) - The inflammation-fighting drug colchicine, already a treatment for gout, dramatically reduces the odds of future cardiovascular problems in people who have just survived a heart ...
- Lower Cholesterol Cuts CV Events: Treat Stroke to Target Trialon November 18, 2019 at 11:02 am
PHILADELPHIA, PA—Prescribing statins to achieve a more aggressive LDL treatment target in patients who have had a TIA or ischemic stroke of atherosclerotic origins reduces the risk of major ...
- Napa’s NeuroSpring develops new medical treatments for stroke patientson November 16, 2019 at 3:00 pm
By studying the rats’ brains, he hopes to determine if a NeuroSpring treatment can affect the animal’s brain when it bleeds, as it does during a stroke. Working for NeuroSpring “is a great ...
- Treatment to ward off stroke less effective in womenon November 15, 2019 at 5:54 am
a key risk factor for stroke. "Men and women are different and sometimes their disease might call for a different treatment approach," said the study's lead investigator Niveditta Ramkumar, a graduate ...
- Stroke among cancer patientson November 15, 2019 at 2:22 am
Our work has limitations. The overall number of deaths from stroke was relatively limited overall (1% of cancer patients), and more detailed analyses on risk factors could not be performed. Treatment ...
- Study finds sex differences in treatment and outcome after strokeon November 14, 2019 at 7:59 am
Women are more likely to survive a stroke, but have worse disability and poorer quality of life afterwards compared to men, according to research published in the latest issue of Neurology ®, the ...
- Stroke Prevention in Atrial Fibrillation (SPAF) Treatment Market to Witness Huge Growth by 2026: Evaluating By Global Leading Playerson November 13, 2019 at 10:05 pm
Nov 14, 2019 (Market Prediction via COMTEX) -- A new research report titled “Global Stroke Prevention in Atrial Fibrillation (SPAF) Treatment market” successfully exhibits the complete scenario of the ...
- New Results: Brainomix Software Shown to Improve Stroke Treatment Rates at Budapest University Hospitalon November 13, 2019 at 4:09 pm
Results Showed e-Stroke Suite Associated with Increase in Thrombolysis and Thrombectomy Treatment Rates for Stroke Patients OXFORD, England, Nov. 12, 2019 /PRNewswire/ -- Last Friday during a ...
- Acute Ischemic Stroke Diagnosis and Treatment Market In Deep Analysis and Research on Health Segment 2025on November 11, 2019 at 10:33 am
Nov 11, 2019 (Market Insight Reports via COMTEX) -- The Acute Ischemic Stroke Diagnosis and Treatment Market recently Published Global Market research study with more than 100 industry informative ...
- Film star Deneuve 'responding well' to treatment after strokeon November 8, 2019 at 10:33 am
Paris (AFP) - French screen legend Catherine Deneuve is recovering well in hospital after suffering a stroke while shooting a film in a hospital, a member of her entourage told AFP on Friday "She is ...
via Bing News